Jeanelle Martinez, Evan Frank, and Thomas Eling
Point of Contact
- Jeanelle Martinez
|Author status||OECD status||OECD project||SAAOP status|
|Under development: Not open for comment. Do not cite||Under Development|
This AOP was last modified on June 23, 2017 10:40
|TRPA1 activation, TRPA1 Receptor||September 16, 2017 10:17|
|Opening of calcium channel, Calcium influx||September 16, 2017 10:17|
|Excitation, Neuron nerve ending excitation||September 16, 2017 10:17|
|SP (Substance P) release, Local increase of SP||September 16, 2017 10:17|
|Trigeminal and/or vagal nerve excitation||September 16, 2017 10:17|
|Immune system inflammation||September 16, 2017 10:17|
|Chronic Cough, Respiratory irritability||December 03, 2016 16:37|
|Generation of novel epitopes , Antigen presentation||December 03, 2016 16:37|
|Sensitization, Immune system||December 03, 2016 16:37|
|Increased CGRP, neuronal release of CGRP||September 16, 2017 10:17|
|Irritation of nasal mucosa inducing sneeze reflex||September 16, 2017 10:17|
|Increased neurokinin A (NKA) by neuronal cells||September 16, 2017 10:17|
|TRPA1 activation, TRPA1 Receptor leads to Opening of calcium channel, Calcium influx||November 29, 2016 21:13|
|Opening of calcium channel, Calcium influx leads to Excitation, Neuron nerve ending excitation||December 03, 2016 16:38|
|Excitation, Neuron nerve ending excitation leads to Nerve excitation||December 03, 2016 16:38|
|Generation of novel epitopes , Antigen presentation leads to Sensitization, Immune system||December 03, 2016 16:38|
|Leukocyte infiltration leads to Sensitization, Immune system||December 03, 2016 16:38|
|SP (Substance P) release, Local increase of SP leads to Nerve excitation||June 23, 2017 11:11|
|Excitation, Neuron nerve ending excitation leads to SP (Substance P) release, Local increase of SP||June 23, 2017 11:14|
|TRPA1 activation, TRPA1 Receptor leads to Generation of novel epitopes , Antigen presentation||June 23, 2017 11:21|
|SP (Substance P) release, Local increase of SP leads to Leukocyte infiltration||June 23, 2017 11:29|
|Excitation, Neuron nerve ending excitation leads to Increased CGRP||June 23, 2017 13:12|
|Increased CGRP leads to Nerve excitation||June 23, 2017 13:14|
|Excitation, Neuron nerve ending excitation leads to Irritation induced sneezing||June 23, 2017 14:42|
|Excitation, Neuron nerve ending excitation leads to Increased NKA||June 23, 2017 16:37|
|Increased NKA leads to Nerve excitation||June 23, 2017 16:38|
|Increased NKA leads to Leukocyte infiltration||June 23, 2017 16:51|
|Increased CGRP leads to Leukocyte infiltration||June 23, 2017 16:51|
|Increased CGRP leads to Chronic Cough, Respiratory irritability||June 27, 2017 18:23|
|Leukocyte infiltration leads to Chronic Cough, Respiratory irritability||December 03, 2016 16:38|
|Dibenzo[B,F][1,4]Oxazepine||January 17, 2017 14:50|
|2-Chlorobenzalmalononitrile||January 20, 2017 11:39|
Pulmonary irritation induced by chemical exposure can be divided into two types. One type of irritation, corrosive irritation causes inflammation from tissue destruction and appears to be limited to inhalation of industrial chemicals for example hydrochloric acid, chlorine gas, and ammonia. The second type, sensory irritation is caused by sensory stimulation mediated by activation of specific receptors located in the trigeminal nerve endings and occurs at concentrations that do not result in tissue destruction. Our focus is to develop an adverse outcome pathway (AOP) for sensory irritants. Many inhalable chemicals are sensory irritants (Alarie et al 1966, 1973, Schaper et al., 1993) that can cause physiological responses including pain, mucus production, nasal obstruction, sneezing, coughing, and decreases in respiration rate (Brunning et al., 2014). The target organ of respiratory irritants is ultimately the airways causing inflammation of the trachea, bronchitis, and bronchiolitis. A receptor present in the upper airways is the TRPA1 (transient receptor potential cation channel, subfamily A, member 1) that induces a physiological response to make the subject aware of the presence of chemicals and initiate several defensive biological responses. A wide range of chemicals activates TRPA1 (Bessac and Jordt, 2010). The activation of TRPA1 acts as a gatekeeper of inflammation/irritation and is a critical endpoint in the regulation of exposure to volatile organic chemicals (Bautista et al., 2013; Lehman et al., 2015).
Exposure to airborne pollutants can cause a number of harmful effects including irritation. Airborne pollutants are typically associated with industrial activities, cigarette smoke and automobile exhaust. However, inhalation exposure to irritant gases and vapors frequently occurs in occupational and ambient environments. Each year new and untested inhalable chemicals are added to the environment and the lack of appropriate toxic information may result in an underestimation of occupation risks due to exposure of airborne irritants. Assays or tests are needed to first determine and then characterize the potential irritant respiratory response of uncharacterized current and newly added volatile chemicals. To develop suitable assays it is necessary to understand the fundamental biochemical and physiology processes initiating the development and progression of irritation. The presented AOP is focused on the critical biochemical event, the activation of the TRP receptors, then describing the subsequent biochemical processes and pathways and how they interact with each other resulting in pulmonary irritation.
Summary of the AOP
Molecular Initiating Event
|TRPA1 activation, TRPA1 Receptor||TRPA1 activation, TRPA1 Receptor|
|Opening of calcium channel, Calcium influx||Opening of calcium channel, Calcium influx|
|Excitation, Neuron nerve ending excitation||Excitation, Neuron nerve ending excitation|
|SP (Substance P) release, Local increase of SP||SP (Substance P) release, Local increase of SP|
|Immune system inflammation||Leukocyte infiltration|
|Generation of novel epitopes , Antigen presentation||Generation of novel epitopes , Antigen presentation|
|Increased CGRP, neuronal release of CGRP||Increased CGRP|
|Increased neurokinin A (NKA) by neuronal cells||Increased NKA|
|Irritation of nasal mucosa inducing sneeze reflex||Irritation induced sneezing|
|Trigeminal and/or vagal nerve excitation||Nerve excitation|
|Chronic Cough, Respiratory irritability||Chronic Cough, Respiratory irritability|
|Sensitization, Immune system||Sensitization, Immune system|
Relationships Between Two Key Events (Including MIEs and AOs)
Life Stage ApplicabilityIs the AOP specific to certain tissues, life stages / age classes? Indicate if there are critical life stages, where exposure must occur, to results in the final adverse effect. Or specify if there are key events along the pathway which are dependent on the life stage although the AOP is known to be initiated regardless of life stage. Indicate also if the AOP is associated also with age- or sex-dependence. Instructions To add a life stage term to an AOP page, under “Life Stage Applicability” select ‘add life stage term.’ User will be directed to a page entitled “Add Life Stage to AOP.” This page will list the AOP name, with drop down menu options to select a Life Stage term and Evidence. Evidence can be left blank and added later. To edit a life stage term on an AOP page, under “Life Stage Applicability” click ‘Edit.’ User will be directed to a page entitled “Editing AOP Life Stage” where they can edit the Evidence field using the drop down menu. Clicking ‘Update Aop life stage’ will update the Evidence field and redirect the user back to the AOP page.
Taxonomic ApplicabilityIndicate the relevant domain of applicability in terms of taxa. Instructions To add a taxonomic term to an AOP page, under “Taxonomic Applicability” select ‘add taxonomic term.’ User will be directed to a page entitled “Adding Taxonomic Term to AOP.” The user can search for and select an existing term from the drop down list of existing terms to populate the “Term” field. If a relevant term does not exist, click ‘Request New Taxon Term’ to request a term from AOP-Wiki administrators. Click ‘Add taxonomic term’ to add this term to the AOP page. Evidence can be left blank and added later. To edit a taxonomic term on an AOP page, under “Taxonomic Applicability” click ‘Edit.’ User will be directed to a page entitled “Editing AOP Taxonomic Term” where they can edit the Evidence field using the drop down menu. Clicking ‘Update taxonomic term’ will update the Evidence field and redirect the user back to the AOP page.
Graphical RepresentationClick to download graphical representation template
Overall Assessment of the AOP
This section addresses the relevant domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and weight of evidence for the overall hypothesised AOP (i.e., including the MIE, KEs and AO) as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). It draws upon the evidence assembled for each KER as one of several components which contribute to relative confidence in supporting information for the entire hypothesised pathway. An important component in assessing confidence in supporting information as a basis to consider regulatory application of AOPs beyond that described in Section 6 is the essentiality of each of the key events as a component of the entire pathway. This is normally investigated in specifically-designed stop/reversibility studies or knockout models (i.e., those where a key event can be blocked or prevented). Assessment of the overall AOP also contributes to the identification of KEs for which confidence in the quantitative relationship with the AO is greatest (i.e., to facilitate determining the most sensitive predictor of the AO). Instructions To edit the “Overall Assessment of the AOP” section, on an AOP page, in the upper right hand menu, click ‘Edit.’ This brings you to a page entitled, “Editing AOP.” Scroll down to the “Overall Assessment of the AOP” section, where a text entry box allows you to submit text. In the upper right hand menu, click ‘Update AOP’ to save your changes and return to the AOP page. The new text should appear under the “Overall Assessment of the AOP” section on the AOP page.
Domain of Applicability
Life Stage Applicability: Exposure to toxic gases and vapor and in particular reactive chemicals activate TRPV1, ASICs and TRPA1 and induce neurogenic inflammation and pain and coughing responses. The activation of TRPA1 and TRPV1 also stimulates the release of inflammatory peptide SP, NKA and CGRP, which play a role in the asthmatic and irritation symptoms, observed after one-time and (Caceres et al., 2009) frequent exposure to inhaled irritants. These receptors may become hyper sensitized leading to chronic airway inflammation and cough. Exposure to high levels of TRPA1 agonists can induce reactive airway dysfunction syndrome or RADS, characterized by asthma like symptoms (Brooks et al., 1985). Bessac and Jordt (2008) proposed that exposure to an irritant and hence activation of TRPA1 may sensitize TRPA1 through inflammatory pathways and thereby establishing a hypersensitivity to other reactive irritants. TRPA1 but not TRPV1 appear to play an important role in allergic airway inflammation and hyper-reactivity associated with asthma. In a mouse model of asthma, the ovalbumin challenged mouse, ovalbumin induces a Th2 directed allergic response that included increase in leukocyte in the bronchoalveolar lavage fluid, increases in inflammatory cytokines and increase mucus production. In TRPA1 (-/-) mice, however these responses to ovalbumin were significantly reduced. Treatment of mice with a tear gas and TRPA1 agonist increased CGRP, SP and neurokinin A in wild type mice with greatly reduced levels in the TRPA1 (-/-) mice appearing in the alveolar fluid. Likewise treatment of wild type mice with ovalbumin also increase increased with level of neurokinin A with a diminished level in the TRPA1 (-/-) mice. These results indicate TRPA1 has a critical role in the development of asthma after allergen challenge (Caceres et al., 2009
Taxonomic Applicability,: The data used to support the KERs in this AOP derives from experimental studies conducted in rats, knockout mice or cell cultures from fibroblasts, ovary epithelium. TRP channels are present in primary sensory neruons, and also non-nueuronal tissues including epithelium, fibroblasts, and smooth muscle (Kissin, 2008). The majority of the KEs in this AOP seem to be highly conserved across species. It is unclear if these KERs of the present AOP are also applicable for other species rather than human, primates, rats and mice.
Sex Applicability: There is definitely potential for sex applicability to play a role in airway irritation and chemical sensitization. It has been demonstrated that TRP channels in sensory neurons are regulated by prolactin, in a sex-dependent manner. Prolactin plays a role in the sensitization of TRP channels and may promote antinocioceeptive effects (Patel, et al., 2013).In female mice dorsal root ganglia neurons, TRPV1 activity was enhanced with prolactin at 10-25 ng/ml whereas male mice required >0.8-1 mcg/ml PRL. ASICs activity has also been shown to be upregulated by prolactin in female rats (Li et al., 2016). </em>
Essentiality of the Key Events
The critical importance of the activation of TRPA1 receptor in the pulmonary response to irritants is strongly supported by the results of studies (Bautista et.al., 2006; Caceres et al., 2009) with mice deficient in TRPA1 (TRPA1-/- mice). The TRPA1 -/- mice have significant lower decrease in the respiration rate and symptoms of irritation after exposure to inhalable irritants than wild type mice. Many electrophiles and oxidants are very potent irritants and covalently link to and modify and thus activate the critical receptor(s) that initiate the irritation response (Bessac and Jordt, 2010, Bautista et al., 2013). Some members of this reactive group are isocyanates, α, β-unsaturated aldehydes, heavy metals and peroxides.
The trigeminal chemosensory nerve endings in the nasal mucosa and airway are a first line of defense against irritant chemicals. In these nerve endings are TRP calcium ion channels, TRPV1 and TRPA1, with TRPA1 acting as the major sensor to noxious chemicals. Irritants, electrophiles, oxidants, as well as endogenous chemicals, activate TRPA1 causing an influx of Ca+2 into the nerve. This results in excitation of the trigeminal nerves and the initiation of airway reflex responses coughing, sneezing and pain. A clear time dependent relationship occurs between the activation of the receptor and Ca ion flux and the biological effects (Bessac et aal., 2008).
Reactive irritants like the isothiocyanates form adducts with thiol residues present in the receptor active site causing prolonged nerve activation (Hinman et al., 2006; Peterlin et al., 2007; Macpherson et al., 2007). The activation of TRPA1 with electrophilic irritants results in the covalent binding of the chemicals to cysteine and lysine residues of TRPA1 forming a “foreign protein” or hapten leading sensitization and enhanced responses to subsequent exposure to the irritant (Vandebriel et al., 2011).
The cellular responses include excitation of the trigeminal nerves causes the release of neuropeptides substance P, NK and CGRP that promote neurogenic inflammation, vasodilation, and fluid leakage. Substance P and NK bind to NK receptors that are expressed in the plasma membrane of cell bodies and dendrites of neurons.
As the irritant reach the lower airways the sensory nerve activation causing the following organ response or pulmonary responses: bronchial constriction spams and increased mucus production and further neurogenic inflammation. Increased eosinophils and T helper cells and the associated inflammatory cytokines (IL-2, Il-4, IL-10, Il-13) are observed (Caceres et al., 2009; Belvisi et al., 2011). Trigeminal activation also results in a vagal response that slows the respiration rate, which is the basis for the use of RD50, or the irritant concentration that induces a 50% decrease in respiration rates in mice (Alarie, 1981).
Exposure to irritants the activation of TRPA1 couples with its interaction with TRPV1 can eventually lead to the following organism responses or clinical manifestations: chronic cough, pain, airway inflammation, COPD and asthmatic like conditions (Bessac and Jordt, 2008, Chen and Haclos, 2015, Baraldi et al., 2010.)
Weight of Evidence Summary
1. Concordance of dose-response relationships Strong in vitro dose response relationships for the activation of TRPA1 by known irritants are published in the literature. In general, a good correlation exists between the potency as measure in vitro and the irritation observed mice in as measure by the Alarie test for sensory irritation.
2. Temporal concordance among the key events and adverse effect; There is good agreement between the sequences of biochemical and physiological events leading to pulmonary irritation ( Bassec and Jordt 2009, Bessac and Jordt, 2010, Baustista et al, 2006).
3. Strength, consistency, and specificity of association of adverse effect and initiating event There is excellent strength, as well as good consistency and high specificity, of the association between the activation of TRP receptors and irritation. The critical importance of the activation of TRPA1 receptor in the pulmonary responses to irritants is strongly supported by the results of studies with mice deficient in TRPA1 (TRPA1-/- mice) (Bautista et.al., 2006; Caceres et al., 2009).
4. Biological plausibility, coherence, and consistency of the experimental evidence The in vitro, and in vivo experimental evidence is logical and consistent with the hypothesis that the activation of the TRP receptors, in particular, the activation of TRPA1 is the key initiation event in pulmonary irritation (Bautista et al 2013, Bessac and Jirdt, 2009).
5. Uncertainties, inconsistencies, and data gaps. A database containing more than 350 RD50 values that is a measure of irritation in vivo obtained from experimental animals is available (Schaper 1993) but only a few of these irritants has been tested in in vitro assays to directly measure the activation of TRPA1 (Bessac and Jordt, 2010; Bos et al., 2002, Lehmann 2016). A real gap in the information of irritation and activation by TRPA1 is the lack of potency data on the activation of TRPA1 by known irritants.
The most effective chemicals with the lowest EC50 to activate the TRPA1 calcium channel are unsurprisingly the electrophiles like tear gases, acrolein, or cinnamaldehyde (Bandell et al., 2004; Jordt et al., 2004; Macpherson et al., 2007; and Mukhopadhyaty et al., 2011). Other chemicals with higher EC50’s include hydrogen peroxide, formaldehye, and Crotonaldehyde (Mukhopadhyaty et al., 2011; Sawada et al., 2008).
Considerations for Potential Applications of the AOP (optional)
The AOP would be enhanced by the addition of results confirming the activation of TRPA1 by the chemicals established as irritants with reported RD50. This information would confirm what irritants and their toxicity is mediate by these biochemical processes initiated by TRPA1 activation. If a significant number of these irritants are not activators of TRP receptors, it would stimulate the search for additional biochemical mechanisms for irritants. Furthermore the additional data would permit a comparison of the RD50 and EC50 . This comparison may allow a determination if an in vitro assay for TRP activation using, for example, fibroblasts can be used determine if an uncharacterized chemical is potential chemical irritant and if the values are useful in setting exposure limits.
Alarie, Y. Dose-response analysis in animal studies: prediction of human responses. Environ Health Perspect 42, 9-13 (1981).
Baraldi, P. G., Preti, D., Materazzi, S. & Geppetti, P. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem 53, 5085-5107, doi:10.1021/jm100062h (2010).
Bautista, D. M. et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124, 1269-1282, doi:10.1016/j.cell.2006.02.023 (2006).
Belvisi, M. G., Dubuis, E. & Birrell, M. A. Transient receptor potential A1 channels: insights into cough and airway inflammatory disease. Chest 140, 1040-1047, doi:10.1378/chest.10-3327 (2011).
Bandell, M. et al. Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin. Neuron 41, 849-857, doi:10.1016/S0896-6273(04)00150-3 (2004).
Bessac, B. F. & Jordt, S. E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 23, 360-370, doi:10.1152/physiol.00026.2008 (2008).
Bessac, B. F. & Jordt, S. E. Sensory detection and responses to toxic gases: mechanisms, health effects, and countermeasures. Proc Am Thorac Soc 7, 269-277, doi:10.1513/pats.201001-004SM (2010).
Bos, P. M., Busschers, M. & Arts, J. H. Evaluation of the sensory irritation test (Alarie test) for the assessment of respiratory tract irritation. J Occup Environ Med 44, 968-976 (2002).
Caceres, A. I. et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A 106, 9099-9104, doi:10.1073/pnas.0900591106 (2009).
Chen, J. & Hackos, D. H. TRPA1 as a drug target--promise and challenges. Naunyn Schmiedebergs Arch Pharmacol 388, 451-463, doi:10.1007/s00210-015-1088-3 (2015).
Hinman, A., Chuang, H. H., Bautista, D. M. & Julius, D. TRP channel activation by reversible covalent modification. Proc Natl Acad Sci U S A 103, 19564-19568, doi:10.1073/pnas.0609598103 (2006).
Jordt, S.-E. et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427, 260-265, doi:http://www.nature.com/nature/journal/v427/n6971/suppinfo/nature02282_S1.html (2004).
Kissin, I. Vanilloid-Induced Conduction Anelgesia: Selective, Dose-Dependent, Long-Lasting, with a Low Level of Potential Neurotoxicity. Anesthesia and analgesia 107, 271-281, doi:10.1213/ane.0b013e318162cfa3 (2008).
Lehmann, R., Hatt, H. & van Thriel, C. Alternative in vitro assays to assess the potency of sensory irritants—Is one TRP channel enough? NeuroToxicology, doi:http://dx.doi.org/10.1016/j.neuro.2016.08.010.
Liu, T. T. et al. Prolactin potentiates the activity of acid-sensing ion channels in female rat primary sensory neurons. Neuropharmacology 103, 174-182, doi:10.1016/j.neuropharm.2015.07.016 (2016).
Macpherson, L. J. et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445, 541-545, doi:10.1038/nature05544 (2007).\
Moldoveanu, B., Otmishi, P., Jani, P., Walker, J., Sarmiento, X., Guardiola, J., … Yu, J. (2009). Inflammatory mechanisms in the lung. Journal of Inflammation Research, 2, 1–11.
Mukhopadhyay, I. et al. Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells. Journal of Receptors and Signal Transduction 31, 350-358, doi:10.3109/10799893.2011.602413 (2011).
Patil, M. J., Ruparel, S. B., Henry, M. A. & Akopian, A. N. Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain. Am. J. Physiol.-Endocrinol. Metab. 305, E1154-E1164, doi:10.1152/ajpendo.00187.2013 (2013).
Peterlin, Z., Chesler, A. & Firestein, S. A painful trp can be a bonding experience. Neuron 53, 635-638, doi:10.1016/j.neuron.2007.02.011 (2007).
Sawada, Y., Hosokawa, H., Matsumura, K. & Kobayashi, S. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide. Eur J Neurosci 27, 1131-1142, doi:10.1111/j.1460-9568.2008.06093.x (2008).
Schaper, M. Development of a Database for Sensory Irritants and its Use in Establishing Occupational Exposure Limits. American Industrial Hygiene Association journal 54, 488-544, doi:10.1080/15298669391355017 (1993).
Vandebriel, R. et al. Respiratory sensitization: advances in assessing the risk of respiratory inflammation and irritation. Toxicol In Vitro 25, 1251-1258, doi:10.1016/j.tiv.2011.04.027 (2011).